Page last updated: 2024-08-24

venlafaxine hydrochloride and Attention Deficit and Disruptive Behavioral Disorders

venlafaxine hydrochloride has been researched along with Attention Deficit and Disruptive Behavioral Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD	1
Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Goldstein, BI; Mayes, T; Onorato, M; Ryan, N; Shamseddeen, W; Spirito, A; Vitiello, B; Wagner, KD; Zelazny, J	1

Trials

2 trial(s) available for venlafaxine hydrochloride and Attention Deficit and Disruptive Behavioral Disorders

Article	Year
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression. Journal of the American Academy of Child and Adolescent Psychiatry, 2013, Volume: 52, Issue:5 Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride	2013
Substance use and the treatment of resistant depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:12 Topics: Adolescent; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit and Disruptive Behavior Disorders; Child Abuse; Child Abuse, Sexual; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Conduct Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Resistance; Drug Therapy, Combination; Family Conflict; Female; Humans; Illicit Drugs; Male; Personality Inventory; Psychometrics; Psychotropic Drugs; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride	2009

Article

Year

Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.

Journal of the American Academy of Child and Adolescent Psychiatry, 2013, Volume: 52, Issue:5

Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride

2013

Substance use and the treatment of resistant depression in adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:12

Topics: Adolescent; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit and Disruptive Behavior Disorders; Child Abuse; Child Abuse, Sexual; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Conduct Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Resistance; Drug Therapy, Combination; Family Conflict; Female; Humans; Illicit Drugs; Male; Personality Inventory; Psychometrics; Psychotropic Drugs; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride

2009